| Metric | შპს ბიომაპას ჯორჯია | შპს გ და გ | შპს პათოლოგიის კვლევითი ცენტრი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾5.3m₾4.3m | ₾6.3m₾10.4m | ₾4.5m₾3.5m |
| Revenue growth | 24.3% | -39.5% | 30.4% |
| Profitability | |||
| EBITDA | ₾290k₾170k | ₾567k₾1.6m | ₾1.0m₾973k |
| EBITDA margin | 5.4%4.0% | 9.0%15.3% | 23.1%28.0% |
| Net profit | ₾229k₾170k | ₾484k₾1.3m | |
| ₾1.0m₾923k |
| Net margin | 4.3%3.9% | 7.7%12.3% | 22.4%26.6% |
| Balance sheet | |||
| Total assets | ₾728k₾577k | ₾1.6m₾501k | ₾3.3m₾2.4m |
| Total equity | ₾699k₾470k | ₾182k₾171k | ₾2.7m₾1.9m |
| ROE | 32.8%36.2% | 266.3%746.9% | 37.4%47.9% |